{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:49:33Z","timestamp":1790603373831,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08400"],"award-info":[{"award-number":["JP21K08400"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K15907"],"award-info":[{"award-number":["JP21K15907"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K17428"],"award-info":[{"award-number":["JP20K17428"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12185-023-03598-8","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T02:01:55Z","timestamp":1681696915000},"page":"494-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome"],"prefix":"10.1007","volume":"118","author":[{"given":"Hiroyoshi","family":"Kunimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kunishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Takase-Minegishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"3598_CR1","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383:2628\u201338.","journal-title":"N Engl J Med"},{"key":"3598_CR2","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","volume":"5","author":"IE Obiorah","year":"2021","unstructured":"Obiorah IE, Patel BA, Groarke EM, Wang W, Trick M, Ombrello AK, et al. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv. 2021;5:3203\u201315.","journal-title":"Blood Adv"},{"key":"3598_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. 2022;186:564\u201374.","journal-title":"Br J Dermatol"},{"key":"3598_CR4","first-page":"3591","volume":"137","author":"PC Grayson","year":"2021","unstructured":"Grayson PC, Patel BA, Young NS. VEXAS syndrome. Blood. 2021;137:3591\u20134.","journal-title":"Blood"},{"key":"3598_CR5","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","volume":"80","author":"N Tsuchida","year":"2021","unstructured":"Tsuchida N, Kunishita Y, Uchiyama Y, Kirino Y, Enaka M, Yamaguchi Y, et al. Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Ann Rheum Dis. 2021;80:1057\u201361.","journal-title":"Ann Rheum Dis"},{"key":"3598_CR6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1182\/blood-2002-01-0256","volume":"100","author":"XT Gregg","year":"2002","unstructured":"Gregg XT, Reddy V, Prchal JT. Copper deficiency masquerading as myelodysplastic syndrome. Blood. 2002;100:1493\u20135.","journal-title":"Blood"},{"key":"3598_CR7","first-page":"129","volume":"169","author":"JA Irving","year":"2003","unstructured":"Irving JA, Mattman A, Lockitch G, Farrell K, Wadsworth LD. Element of caution: a case of reversible cytopenias associated with excessive zinc supplementation. CMAJ. 2003;169:129\u201331.","journal-title":"CMAJ"},{"key":"3598_CR8","first-page":"487","volume":"13","author":"KY Yeung","year":"1988","unstructured":"Yeung KY, Klug PP, Lessin LS. Alcohol-induced vacuolization in bone marrow cells: ultrastructure and mechanism of formation. Blood Cells. 1988;13:487\u2013502.","journal-title":"Blood Cells"},{"key":"3598_CR9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1182\/blood.V81.4.1040.1040","volume":"81","author":"P Mathew","year":"1993","unstructured":"Mathew P, Tefferi A, Dewald GW, Goldberg SL, Su J, Hoagland HC, et al. The 5q- syndrome: a single-institution study of 43 consecutive patients. Blood. 1993;81:1040\u20135.","journal-title":"Blood"},{"key":"3598_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000661","volume":"5","author":"MHGP Raaijmakers","year":"2021","unstructured":"Raaijmakers MHGP, Hermans M, Aalbers A, Rijken M, Dalm VASH, van Daele P, et al. Azacytidine treatment for VEXAS syndrome. Hemasphere. 2021;5: e661.","journal-title":"Hemasphere"},{"key":"3598_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s44228-022-00002-w","volume":"4","author":"M Manzoni","year":"2022","unstructured":"Manzoni M, Bosi A, Fabris S, Lionetti M, Salerio S, Migliorini AC, et al. Clinical, morphological and clonal progression of VEXAS syndrome in the context of myelodysplasia treated with Azacytidine. Clin Hematol Int. 2022;4:52\u20135.","journal-title":"Clin Hematol Int"},{"key":"3598_CR12","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2169\/internalmedicine.40.1041","volume":"40","author":"K Funato","year":"2001","unstructured":"Funato K, Kuriyama Y, Uchida Y, Suzuki A, Miyazawa K, Ohyashiki K. Myelodysplastic syndrome accompanied by Addison\u2019s disease and multiple autoimmune phenomena: steroid therapy resolved cytopenias and all immune disorders. Intern Med. 2001;40:1041\u20134.","journal-title":"Intern Med"},{"key":"3598_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29138","volume":"68","author":"AD Yanir","year":"2021","unstructured":"Yanir AD, Krauss A, Stein J, Steinberg-Shemer O, Gilad O, Lotan SN, et al. Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome. Pediatr Blood Cancer. 2021;68: e29138.","journal-title":"Pediatr Blood Cancer"},{"key":"3598_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/1042819021000055345","volume":"44","author":"T Shimamoto","year":"2003","unstructured":"Shimamoto T, Ohyashiki K. Immunosuppressive treatments for myelodysplastic syndromes. Leuk Lymphoma. 2003;44:593\u2013604.","journal-title":"Leuk Lymphoma"},{"key":"3598_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00277-005-1016-6","volume":"84","author":"A Dixit","year":"2005","unstructured":"Dixit A, Chatterjee T, Mishra P, Choudhary DR, Mahapatra M, Saxena R, et al. Cyclosporin A in myelodysplastic syndrome: a preliminary report. Ann Hematol. 2005;84:565\u20138.","journal-title":"Ann Hematol"},{"key":"3598_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1532\/IJH97.A10513","volume":"85","author":"S Chen","year":"2007","unstructured":"Chen S, Jiang B, Da W, Gong M, Guan M. Treatment of myelodysplastic syndrome with cyclosporin A. Int J Hematol. 2007;85:11\u20137.","journal-title":"Int J Hematol"},{"key":"3598_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133:40\u201350.","journal-title":"Blood"},{"key":"3598_CR18","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra1804281","volume":"381","author":"T Ganz","year":"2019","unstructured":"Ganz T. Anemia of inflammation. N Engl J Med. 2019;381:1148\u201357.","journal-title":"N Engl J Med"},{"key":"3598_CR19","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1182\/blood.2022016985","volume":"140","author":"MA Ferrada","year":"2022","unstructured":"Ferrada MA, Savic S, Ospina Cardona D, Collins JC, Alessi H, Gutierrez-Rodrigues F, et al. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood. 2022;140:1496\u2013506.","journal-title":"Blood"},{"key":"3598_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bjh.17893","volume":"196","author":"T Comont","year":"2022","unstructured":"Comont T, Heiblig M, Rivi\u00e9re E, Terriou L, Rossignol J, Bouscary D, et al. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry. Br J Haematol. 2022;196:969\u201374.","journal-title":"Br J Haematol"},{"key":"3598_CR21","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1136\/annrheumdis-2021-220876","volume":"80","author":"Y Kirino","year":"2021","unstructured":"Kirino Y, Takase-Minegishi K, Tsuchida N, Hirahara L, Kunishita Y, Yoshimi R, et al. Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan. Ann Rheum Dis. 2021;80:1501\u20132.","journal-title":"Ann Rheum Dis"},{"key":"3598_CR22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/blood.2022016642","volume":"140","author":"M Heiblig","year":"2022","unstructured":"Heiblig M, Ferrada MA, Koster MJ, Barba T, Gerfaud-Valentin M, M\u00e9kinian A, et al. Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study. Blood. 2022;140:927\u201331.","journal-title":"Blood"},{"key":"3598_CR23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1182\/bloodadvances.2021004749","volume":"6","author":"A Diarra","year":"2022","unstructured":"Diarra A, Duployez N, Fournier E, Preudhomme C, Coiteux V, Magro L, et al. Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience. Blood Adv. 2022;6:998\u20131003.","journal-title":"Blood Adv"},{"key":"3598_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrc3911","volume":"15","author":"N Ratner","year":"2015","unstructured":"Ratner N, Miller SJ. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer. 2015;15:290\u2013301.","journal-title":"Nat Rev Cancer"},{"key":"3598_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.629994","volume":"8","author":"T Xiao","year":"2021","unstructured":"Xiao T, Xie Y, Zhang X, Xu K, Zhang X, Jin ZB, et al. Variant profiling of a large cohort of 138 Chinese families with autosomal dominant retinitis pigmentosa. Front Cell Dev Biol. 2021;8: 629994.","journal-title":"Front Cell Dev Biol"},{"key":"3598_CR26","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1002\/ajmg.a.62772","volume":"188","author":"L O\u2019Grady","year":"2022","unstructured":"O\u2019Grady L, Schrier Vergano SA, Hoffman TL, Sarco D, Cherny S, Bryant E, et al. Heterozygous variants in PRPF8 are associated with neurodevelopmental disorders. Am J Med Genet. 2022;188:2750\u20139.","journal-title":"Am J Med Genet"},{"key":"3598_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12885-022-09347-0","volume":"22","author":"X Wu","year":"2022","unstructured":"Wu X, Deng J, Zhang N, Liu X, Zheng X, Yan T, et al. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation. BMC Cancer. 2022;22:262.","journal-title":"BMC Cancer"},{"key":"3598_CR28","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122:3616\u201327.","journal-title":"Blood"},{"key":"3598_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28:241\u20137.","journal-title":"Leukemia"},{"key":"3598_CR30","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/leu.2016.138","volume":"30","author":"A Nazha","year":"2016","unstructured":"Nazha A, Narkhede M, Radivoyevitch T, Seastone DJ, Patel BJ, Gerds AT, et al. Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes. Leukemia. 2016;30:2214\u201320.","journal-title":"Leukemia"},{"key":"3598_CR31","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1200\/JCO.2011.40.7379","volume":"30","author":"R Bejar","year":"2012","unstructured":"Bejar R, Stevenson KE, Caughey BS, Abdel-Wahab O, Steensma DP, Galili N, et al. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J Clin Oncol. 2012;30:3376\u201382.","journal-title":"J Clin Oncol"},{"key":"3598_CR32","doi-asserted-by":"publisher","first-page":"14172","DOI":"10.18632\/oncotarget.7290","volume":"7","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Patel K, Bueso-Ramos C, Zhang J, Gumbs C, Jabbour E, et al. Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents. Oncotarget. 2016;7:14172\u201387.","journal-title":"Oncotarget"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03598-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03598-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03598-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:18:48Z","timestamp":1695730728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03598-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3598"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03598-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"26 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}